3 days ago · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term moderate to severe pain. includes Journavx side effects, uses, interactions, and more.

6 days ago · The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.

5 days ago · The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

6 days ago · Vertex's medication, named Journavx, is seen as a major development in the ongoing effort to provide effective pain management solutions without the harmful …

Jan 30, 2025 · “With the approval of JOURNAVX, a non-opioid, pain signal inhibitor and the first new class of pain medicine approved in more than 20 years, we have the opportunity to …

6 days ago · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

5 days ago · FDA approves first non-opioid pain medicine in more than 20 years The drug, Journavx (suzetrigine), inhibits an ion channel in peripheral nerves.

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Jan 30, 2025 · The FDA today approved nonopioid Journavx (suzetrigine) for management of moderate to severe acute pain. The novel highly selective voltage-gated sodium channel …

5 days ago · The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment